nach oben

International Cancer Conference Journal

Erschienen in:

08.10.2019 | Case report

A case report and review of the literature: cardiotoxicities after radiotherapy for breast cancer patients with high-risk factors of cardiovascular disease

verfasst von: Liuwei Tang, Haruo Matsushita, Yojiro Ishikawa, Takanori Ishida, Keiichi Jingu

Erschienen in: International Cancer Conference Journal | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular disease (CVD) is an important adverse effect of radiotherapy and is responsible for increased morbidity and mortality in long-term survivors with breast cancer. Patients may have pre-existing cardiovascular risk factors before treatment of breast cancer, and the effects of pre-existing cardiovascular risk factors can be compounded by radiotherapy. We report a case of left breast cancer in a 63-year-old female with a high risk of CVD who was suspected of having radiation-induced myocardium injury 1 year after postoperative adjuvant therapy. Radiation oncologists should not only reduce the adverse effects by perfecting radiotherapy technology but also consider reducing other high-risk factors for CVD.

Tang L, Matsushita H, Jingu K (2018) Controversial issues in radiotherapy after breast-conserving surgery for early breast cancer in older patients: a systematic review. J Radiat Res 59(6):789–793CrossRef

Jingu K (2017) Radiation-induced heart disease after treatment for esophageal cancer. Esophagus 14(3):215–220CrossRef

Taylor CW, Kirby AM (2015) Cardiac Side-effects From Breast Cancer Radiotherapy. Clin Oncol (R Coll Radiol) 27(11):621–629CrossRef

Zagar TM, Cardinale DM, Marks LB (2016) Breast cancer therapy-associated cardiovascular disease. Nat Rev Clin Oncol 13(3):172–184CrossRef

Abdel-Qadir H, Austin PC, Lee DS et al (2017) A population-based study of cardiovascular mortality following early-stage breast cancer. JAMA Cardiol 2(1):88–93CrossRef

Drozdz D, Kawecka-Jaszcz K (2014) Cardiovascular changes during chronic hypertensive states. Pediatr Nephrol 29(9):1507–1516CrossRef

Shen L, Ma H, Xiang MX et al (2013) Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease. Am J Cardiol 112(2):266–271CrossRef

Kannel WB (2009) Hypertension: reflections on risks and prognostication. Med Clin North Am 93(3):541–558 (Table of Contents)CrossRef

Lau DC, Shen GX (2013) Cardiovascular complications of diabetes. Can J Diabetes 37(5):279–281CrossRef

10.

Kenchaiah S, Evans JC, Levy D et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313CrossRef

11.

de Azambuja E, McCaskill-Stevens W, Francis P et al (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02–98 trial. Breast Cancer Res Treat 119(1):145–153CrossRef

12.

Suter TM, Ewer MS (2013) Cancer drugs and the heart: importance and management. Eur Heart J 34(15):1102–1111CrossRef

13.

Lage R, Cebro-Marquez M, Rodriguez-Manero M et al (2019) Omentin protects H9c2 cells against docetaxel cardiotoxicity. PLoS ONE 14:2CrossRef

14.

Iqubal A, Iqubal MK, Sharma S et al (2019) Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision. Life Sci 218:112–131CrossRef

15.

Shakir DK, Rasul KI (2009) Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management. J Clin Med Res 1(1):8–12PubMedPubMedCentral

16.

Haque R, Shi J, Schottinger JE et al (2016) Cardiovascular disease after aromatase inhibitor use. JAMA Oncol 2(12):1590–1597CrossRef

17.

Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998CrossRef

18.

Heidenreich PA, Kapoor JR (2009) Radiation induced heart disease: systemic disorders in heart disease. Heart 95(3):252–258CrossRef

19.

Jingu K, Kaneta T, Nemoto K et al (2006) The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 66(3):845–851CrossRef

20.

Evans JD, Gomez DR, Chang JY et al (2013) Cardiac (1)(8)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol 109(1):82–88CrossRef

Titel: A case report and review of the literature: cardiotoxicities after radiotherapy for breast cancer patients with high-risk factors of cardiovascular disease
verfasst von: Liuwei Tang
Haruo Matsushita
Yojiro Ishikawa
Takanori Ishida
Keiichi Jingu
Publikationsdatum: 08.10.2019
Verlag: Springer Singapore
Erschienen in: International Cancer Conference Journal / Ausgabe 1/2020
Elektronische ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-019-00390-6

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

A case report and review of the literature: cardiotoxicities after radiotherapy for breast cancer patients with high-risk factors of cardiovascular disease

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Rectal cancer with extensive distal intramural spread treated by abdominoperineal resection

Adrenal leiomyosarcoma in a young adult male

A patient with a pancreatic neuroendocrine tumor and multiple liver metastases achieved a long-term partial response to third-line streptozocin treatment

A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil

Two cases of anaphylaxis due to contrast media during administration of nivolumab and ipilimumab in metastatic renal cell carcinoma

Retroperitoneal extragonadal germ cell tumor without distant metastasis: a case report

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie